Works matching IS 14248247 AND DT 2014 AND VI 7 AND IP 2
Results: 5
Design of Prodrugs to Enhance Colonic Absorption by Increasing Lipophilicity and Blocking Ionization.
- Published in:
- Pharmaceuticals (14248247), 2014, v. 7, n. 2, p. 207, doi. 10.3390/ph7020207
- By:
- Publication type:
- Article
Mitochondrial FAD-linked Glycerol-3-phosphate Dehydrogenase: A Target for Cancer Therapeutics.
- Published in:
- Pharmaceuticals (14248247), 2014, v. 7, n. 2, p. 192, doi. 10.3390/ph7020192
- By:
- Publication type:
- Article
The Dipeptide Monoester Prodrugs of Floxuridine and Gemcitabine--Feasibility of Orally Administrable Nucleoside Analogs.
- Published in:
- Pharmaceuticals (14248247), 2014, v. 7, n. 2, p. 169, doi. 10.3390/ph7020169
- By:
- Publication type:
- Article
Mercury-Supported Biomimetic Membranes for the Investigation of Antimicrobial Peptides.
- Published in:
- Pharmaceuticals (14248247), 2014, v. 7, n. 2, p. 136, doi. 10.3390/ph7020136
- By:
- Publication type:
- Article
From Single Target to Multitarget/Network Therapeutics in Alzheimer's Therapy.
- Published in:
- Pharmaceuticals (14248247), 2014, v. 7, n. 2, p. 113, doi. 10.3390/ph7020113
- By:
- Publication type:
- Article